These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33752302)

  • 1. Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma.
    Jung H; Kim K; Kim D; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
    Endocrinol Metab (Seoul); 2021 Apr; 36(2):342-350. PubMed ID: 33752302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission.
    Freda PU; Chung WK; Matsuoka N; Walsh JE; Kanibir MN; Kleinman G; Wang Y; Bruce JN; Post KD
    Pituitary; 2007; 10(3):275-82. PubMed ID: 17594522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH/PRL-secreting pituitary macroadenoma associated with GNAS p.Gln227Leu mutation: pediatric case report and review.
    Watanabe D; Yagasaki H; Kojika S; Ogiwara M; Kinouchi H; Nakane T; Inukai T
    Endocr J; 2019 May; 66(5):403-408. PubMed ID: 30814395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.
    Vortmeyer AO; Gläsker S; Mehta GU; Abu-Asab MS; Smith JH; Zhuang Z; Collins MT; Oldfield EH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2404-13. PubMed ID: 22564667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSPalpha mutations in Mexican patients with acromegaly: potential impact on long term prognosis.
    Mendoza V; Sosa E; Espinosa-de-Los-Monteros AL; Salcedo M; Guinto G; Cheng S; Sandoval C; Mercado M
    Growth Horm IGF Res; 2005 Feb; 15(1):28-32. PubMed ID: 15701569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma.
    Matsumoto R; Izawa M; Fukuoka H; Iguchi G; Odake Y; Yoshida K; Bando H; Suda K; Nishizawa H; Takahashi M; Inoshita N; Yamada S; Ogawa W; Takahashi Y
    Endocr J; 2016 Nov; 63(11):953-963. PubMed ID: 27498687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomas.
    Ritvonen E; Pitkänen E; Karppinen A; Vehkavaara S; Demir H; Paetau A; Schalin-Jäntti C; Karhu A
    Eur J Endocrinol; 2017 Feb; 176(2):243-252. PubMed ID: 27998919
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Tang C; Zhong C; Zhu J; Yuan F; Yang J; Xu Y; Ma C
    Oncol Res; 2024; 32(6):1079-1091. PubMed ID: 38827318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.
    Hage M; Chaligné R; Viengchareun S; Villa C; Salenave S; Bouligand J; Letouzé E; Tosca L; Rouquette A; Tachdjian G; Parker F; Lombès M; Lacroix A; Gaillard S; Chanson P; Kamenický P
    J Clin Endocrinol Metab; 2019 May; 104(5):1777-1787. PubMed ID: 30376114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant.
    Ku CR; Lim H; Lee YJ; Kim SH; Kim D; Kim SH; Lee MK; Bang D; Lee EJ
    Sci Rep; 2021 Aug; 11(1):16530. PubMed ID: 34400688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation.
    Lania AG; Ferrero S; Pivonello R; Mantovani G; Peverelli E; Di Sarno A; Beck-Peccoz P; Spada A; Colao A
    J Clin Endocrinol Metab; 2010 Jan; 95(1):13-7. PubMed ID: 19890024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
    Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients.
    Taghvaei M; Sadrehosseini SM; Ardakani JB; Nakhjavani M; Zeinalizadeh M
    World Neurosurg; 2018 Sep; 117():e259-e268. PubMed ID: 29902603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
    Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
    Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly.
    Park SH; Ku CR; Moon JH; Kim EH; Kim SH; Lee EJ
    J Clin Endocrinol Metab; 2018 Mar; 103(3):909-916. PubMed ID: 29272449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
    Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
    J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    Taweesomboonyat C; Oearsakul T
    World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study.
    Zhang S; Chen J; Yao S; Akter F; Wang Z; Hu B; Zhu D; Duan C; Chen W; Zhu Y; Wang H; Mao Z
    J Endocrinol Invest; 2023 Mar; 46(3):465-476. PubMed ID: 36125731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.